3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian Neoplasms
21
Neoplasms
16
Neuroblastoma
14
Small Cell Lung Carcinoma
13
Carcinoma, Ovarian Epithelial
12
Fallopian Tube Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lung Neoplasms
10
Recurrence
8
Leukemia
8
Leukemia, Myeloid, Acute
7
Uterine Cervical Neoplasms
6
Unspecified Adult Solid Tumor, Protocol Specific
6
Neoplasm Metastasis
6
Lymphoma
6
Sarcoma, Ewing
5
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Sarcoma
4
Lymphoma, Follicular
4
Glioma
4
Central Nervous System Neoplasms
4
Burkitt Lymphoma
4
Blast Crisis
4
Rhabdomyosarcoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Meningeal Carcinomatosis
3
Medulloblastoma
3
Interventions
Topotecan
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Meningitis
×
Topotecan
×
Clear all
NCT00674674
2012-05-15
PBTC-019
Baylor College of Medicine
Phase 1
Completed
22 enrolled